PMID- 36324694
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20221104
IS  - 1663-9812 (Print)
IS  - 1663-9812 (Electronic)
IS  - 1663-9812 (Linking)
VI  - 13
DP  - 2022
TI  - Positive short term effects of an integrative korean medicine treatment package 
      for low back pain caused by motor vehicle accidents: A retrospective chart review 
      of real - world practice data.
PG  - 1003849
LID - 10.3389/fphar.2022.1003849 [doi]
LID - 1003849
AB  - Backgrounds No standard treatment exist for reducing symptoms related to sequelae 
      of motor vehicle accidents (MVAs). In Korea, comprehensive Korean Medicine (KM) 
      treatment that includes botanical drugs (herbal medicine), acupuncture, 
      pharmacopuncture, tuina, moxibustion, and cupping is covered by automobile 
      insurance and increasingly used to help alleviate such pain. This study aimed to 
      analyze real-world data and to evaluate the effectiveness and safety of 
      comprehensive KM treatment for low back pain caused by MVAs. Methods We conducted 
      a retrospective chart review of patients who received KM treatment during 
      hospitalization. Records that lacked follow-up outcome assessments were excluded. 
      The Verbal Numerical Rating Scale (VNRS), the Korean version of the Oswestry 
      Disability Index (K-ODI) and the Korean version of the Roland-Morris Disability 
      Questionnaire (K-RMDQ) were evaluated at admission and discharge. Adverse events 
      were also analyzed. A paired t-test was used to identify the effectiveness of KM 
      treatment. Results A total of 50 patients, 30 males and 20 females, were included 
      in the analysis. The mean age of the patients was 40.72 +/- 13.31 years and the 
      average treatment period was 7.22 +/- 3.84 days. After treatment, VNRS, K-ODI and 
      K-RMDQ were significantly improved (p < 0.001). There was a decrease from 5.06 +/- 
      1.60 to 3.40 +/- 1.81 in VNRS, 33.38 +/- 16.88 to 24.54 +/- 13.63 in K-ODI, and 6.84 +/- 
      6.27 to 4.14 +/- 4.38 in K-RMDQ. During this period, a total of two adverse events 
      were reported. Discussion Although this retrospective chart review looked into 
      the short term effects only, comprehensive KM treatment might be an effective and 
      safe therapeutic option to reduce acute low back pain especially after MVA. 
      Prospective research data is needed to support this hypothesis.
CI  - Copyright (c) 2022 Park, Lee, Yoon, Jo, Kim, Kim, Sul and Leem.
FAU - Park, Hye-Rin
AU  - Park HR
AD  - Chung-Yeon Korean Medicine Hospital, Gwangju, South Korea.
FAU - Lee, Seungmin Kathy
AU  - Lee SK
AD  - Virginia University of Integrative Medicine, Fairfax, VA, United States.
AD  - QualTEAM Academy, Seoul, South Korea.
FAU - Yoon, Sang-Hoon
AU  - Yoon SH
AD  - Chung-Yeon Korean Medicine Clinic, Seoul, South Korea.
FAU - Jo, Hee-Geun
AU  - Jo HG
AD  - Department of Herbal Pharmacology, College of Korean Medicine, Gachon University, 
      Seongnam, South Korea.
FAU - Kim, Ji-Yong
AU  - Kim JY
AD  - Jayoenanae Korean Medicine Clinic, Busan, South Korea.
FAU - Kim, Hyunho
AU  - Kim H
AD  - QualTEAM Academy, Seoul, South Korea.
FAU - Sul, Jae-Uk
AU  - Sul JU
AD  - Department of Korean Rehabilitation Medicine, Dongshin University Korean Medicine 
      Hospital, Gwangju, South Korea.
FAU - Leem, Jungtae
AU  - Leem J
AD  - College of Korean Medicine, Wonkwang University, Iksan, South Korea.
LA  - eng
PT  - Journal Article
DEP - 20221017
PL  - Switzerland
TA  - Front Pharmacol
JT  - Frontiers in pharmacology
JID - 101548923
PMC - PMC9618792
OTO - NOTNLM
OT  - Korean medicine
OT  - acupuncture
OT  - botanical drug
OT  - herbal medicine
OT  - integrative medicine
OT  - low back pain
OT  - motor vehicle accident
OT  - real world data
COIS- The authors declare that the research was conducted in the absence of any 
      commercial or financial relationships that could be construed as a potential 
      conflict of interest.
EDAT- 2022/11/04 06:00
MHDA- 2022/11/04 06:01
PMCR- 2022/10/17
CRDT- 2022/11/03 02:32
PHST- 2022/07/26 00:00 [received]
PHST- 2022/09/29 00:00 [accepted]
PHST- 2022/11/03 02:32 [entrez]
PHST- 2022/11/04 06:00 [pubmed]
PHST- 2022/11/04 06:01 [medline]
PHST- 2022/10/17 00:00 [pmc-release]
AID - 1003849 [pii]
AID - 10.3389/fphar.2022.1003849 [doi]
PST - epublish
SO  - Front Pharmacol. 2022 Oct 17;13:1003849. doi: 10.3389/fphar.2022.1003849. 
      eCollection 2022.